Introduction. Gastrointestinal bleeding represents the main indication for emergency endoscopy (EE). Lately, several hemostatic powders have been released to facilitate EE. Methods. We evaluated all EE in which Hemospray was used as primary or salvage therapy, with regard to short-and long-term hemostasis and complications. Results. We conducted 677 EE in 474 patients (488 examinations in 344 patients were upper GI endoscopies). Hemospray was applied during 35 examinations in 27 patients (19 males), 33 during upper and 2 during lower endoscopy. It was used after previous treatment in 21 examinations (60%) and in 14 (40%) as salvage therapy. Short-term success was reached in 34 of 35 applications (97.1%), while long-term success occurred in ...
Acute gastrointestinal bleeding is a common cause of hospitalization and remains an important cause ...
Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastroint...
Background: Hemospray TM (TC-325) is a novel hemostatic agent licensed for use in nonvariceal upper ...
Introduction. Gastrointestinal bleeding represents the main indication for emergency endoscopy (EE)....
Background: Hemospray is a new endoscopic haemostatic powder that can be used in the management of u...
Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of up...
Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of up...
Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of up...
INTRODUCTION: With increasing advances in minimally invasive endoscopic therapies and endoscopic res...
INTRODUCTION: With increasing advances in minimally invasive endoscopic therapies and endoscopic res...
AbstractAcute gastrointestinal bleeding is among the most urgent situations in daily gastroenterolog...
AIM: To define the role of endoscopic hemostasis in treatment of gastroduodenal ulcers complicated b...
Hemospray TM (TC-325) is a novel hemostatic agent licensed for use in nonvariceal upper gastrointest...
AIM: To define the role of endoscopic hemostasis in treatment of gastroduodenal ulcers complicated b...
During the past 20 years, endoscopy has developed as the modality of choice for determining diagnosi...
Acute gastrointestinal bleeding is a common cause of hospitalization and remains an important cause ...
Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastroint...
Background: Hemospray TM (TC-325) is a novel hemostatic agent licensed for use in nonvariceal upper ...
Introduction. Gastrointestinal bleeding represents the main indication for emergency endoscopy (EE)....
Background: Hemospray is a new endoscopic haemostatic powder that can be used in the management of u...
Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of up...
Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of up...
Background Hemospray is a new endoscopic haemostatic powder that can be used in the management of up...
INTRODUCTION: With increasing advances in minimally invasive endoscopic therapies and endoscopic res...
INTRODUCTION: With increasing advances in minimally invasive endoscopic therapies and endoscopic res...
AbstractAcute gastrointestinal bleeding is among the most urgent situations in daily gastroenterolog...
AIM: To define the role of endoscopic hemostasis in treatment of gastroduodenal ulcers complicated b...
Hemospray TM (TC-325) is a novel hemostatic agent licensed for use in nonvariceal upper gastrointest...
AIM: To define the role of endoscopic hemostasis in treatment of gastroduodenal ulcers complicated b...
During the past 20 years, endoscopy has developed as the modality of choice for determining diagnosi...
Acute gastrointestinal bleeding is a common cause of hospitalization and remains an important cause ...
Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastroint...
Background: Hemospray TM (TC-325) is a novel hemostatic agent licensed for use in nonvariceal upper ...